AKBA
Akebia Therapeutics Inc.
NASDAQ · Healthcare
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating | ||||||||||
| Operating Cash Flow | — | — | — | — | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — | — | — | — | — |
| Investing | ||||||||||
| Capital Expenditures | 291,000 | 33,000 | 0 | 114,000 | 59,000 | 317,000 | 6.7M | 1.6M | 1.6M | 2.7M |
| Acquisitions | — | — | — | — | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — | — | — | — | — |
| Financing | ||||||||||
| Debt Repayment | — | — | — | — | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — | — | — | — | — |
| Summary | ||||||||||
| Free Cash Flow | 67.7M | -40.7M | -23.4M | -73.3M | -253.0M | -110.7M | -264.1M | -99.1M | -57.8M | 55.2M |
| Net Change in Cash | — | — | — | — | — | — | — | — | — | — |